News

Arrowhead Pharmaceuticals' Major Licensing Deal with Sarepta

Arrowhead Pharmaceuticals' Major Licensing Deal with Sarepta

Arrowhead Pharmaceuticals and Sarepta Collaboration

Recently, Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) finalized a global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ: SRPT). This collaboration marks a significant milestone for both companies, enhancing their potential in the biotechnology sector.

Financial Overview of the Agreement

The closing of the agreement comes with a robust financial framework that includes an upfront payment of $500 million to Arrowhead. In addition, Sarepta is acquiring common stock from Arrowhead at a price of $27.25 per share, contributing an additional $325 million.

Furthermore, Arrowhead stands to gain $250 million over five years, paid in annual installments of $50 million. An exciting aspect of this deal is the $300 million that Arrowhead may receive in near-term payments tied to the continual enrollment of participants in a Phase 1/2 clinical study of ARO-DM1, projected to occur within the upcoming year.

Potential Milestone Payments

As part of the agreement, Arrowhead is poised to receive development milestone payments ranging from $110 million to $410 million per program, along with sales milestones between $500 million and $700 million per program. The company is also entitled to tiered royalties on commercial sales that could reach into the low double digits, a substantial opportunity for revenue generation.

Programs Under the License Agreement

This partnership encompasses several innovative programs aimed at significant medical needs. In the clinical stage, Arrowhead is advancing:

ARO-DUX4

This program targets the gene encoding the DUX4 protein to potentially treat patients suffering from facioscapulohumeral muscular dystrophy type 1. It is currently progressing through a Phase 1/2 clinical study and is actively dosing patients.

ARO-DM1

Designed to reduce the expression of the dystrophia myotonica protein kinase (DMPK) gene in skeletal muscle, this program aims to assist those with type 1 myotonic dystrophy, also in clinical trials.

ARO-MMP7

This initiative focuses on targeting matrix metalloproteinase 7 (MMP7) to potentially treat idiopathic pulmonary fibrosis, and it is likewise in the dosing phase of its clinical study.

ARO-ATXN2

Aiming to silence the toxic ATXN2 protein in the central nervous system, this program is in its Phase 1/2 study and is currently open for enrollment.

Emerging Programs and Future Aspirations

In the preclinical stage, Arrowhead is working on several promising programs, including:

ARO-HTT

This project, targeted at treating Huntington's disease, is expected to be ready for a clinical trial application in the near future.

ARO-ATXN1

Aimed at spinocerebellar ataxia 1 (SCA1), this program is anticipated to reach CTA readiness in the coming years.

ARO-ATXN3

Focusing on spinocerebellar ataxia 3 (SCA3), this initiative also expects to be prepared for a clinical trial application soon.

Collaboration in Drug Development

The collaboration stipulates that during the five-year agreement duration, Sarepta may present up to six new central nervous system (CNS) or muscle targets for Arrowhead to explore in discovery and preclinical development. Sarepta will acquire exclusive rights to these programs, managing their clinical advancement and market availability.

Manufacturing Capabilities

Under this collaboration, Arrowhead will take charge of manufacturing the clinical supply of drugs stemming from the licensing agreement and ensuring a supply for the four ongoing clinical trial programs.

About Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals is known for its innovative approach to battling hard-to-treat diseases through gene silencing. Utilizing a diverse array of RNA chemistries and effective delivery mechanisms, Arrowhead harnesses RNA interference (RNAi) technology to promote the knockdown of specific disease-causing genes. This exciting method employs a natural cellular process to silence problematic genes, offering hope for the development of groundbreaking therapeutics.

Frequently Asked Questions

What is the purpose of the licensing agreement between Arrowhead and Sarepta?

The agreement aims to enhance Arrowhead's development capabilities and provide Sarepta with innovative therapeutic candidates to progress through clinical development.

What is ARO-DM1?

ARO-DM1 is a treatment program designed to lessen the expression of the DMPK gene associated with type 1 myotonic dystrophy.

How much is Arrowhead receiving upfront from the licensing deal?

Arrowhead is receiving a significant upfront payment of $500 million as part of the agreement.

What milestone payments can Arrowhead expect?

Arrowhead is eligible for milestone payments ranging from $110 million to $410 million per program, plus sales milestones that could reach up to $700 million.

What is the significance of RNA interference technology?

RNA interference technology allows Arrowhead to effectively silence disease-causing genes, offering a powerful mechanism for developing new treatments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Branch's Fast 500 Rank Signals Payroll Platform Reach

Updated Category News Views 118

Six straight appearances on Deloitte's Fast 500 is not random confetti; it says Branch has kept finding customers while plenty of fintech outfits were busy shrinking their ambitions. The Tampa-based workforce-payments company landed at No. 146 in the 2026 ranking, which measures fiscal-year revenue growth from 2022 through 2025. That is a respectable showing in a list...

Continue Reading
Northgate’s Stanton Opening Puts Community Work First

Updated Category News Views 100

A 55,721-square-foot grocery opening can look like ordinary retail churn until you notice where the money and attention are landing. Northgate González Market’s new Stanton location arrives ahead of Thanksgiving, yes, but the more telling detail is the company’s decision to pair a major store launch with 375 jobs and more than $30,000 directed toward families,...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 44

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 95

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 76

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading
Franklin County Trees Raise Funds and Honor Veterans

Updated Category News Views 66

Holiday charity works best when it gives people something tangible to gather around, and Franklin County has found a pretty sturdy version of that formula. Its eighth annual Festival of Trees opens at 4 p.m. Saturday, November 21, at the Franklin County 11/30 Visitors Center in downtown Chambersburg, carrying the theme A Salute To Veterans. More than 80 decorated trees...

Continue Reading
E-Rate Risk and Data Center Rules Demand Attention

Updated Category News Views 71

America’s digital plumbing is getting squeezed at both ends: the public connections nobody notices until they fail, and the industrial-scale computing boom everybody suddenly wants built yesterday. Connected Nation’s two bonus podcast episodes from the Broadband Nation Expo in New Orleans put those pressures side by side, and it is a more useful pairing than it may...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 89

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Straub's Court Win Raises Cost of Seven-Year Fight

Updated Category News Views 87

Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...

Continue Reading
YPTC’s Florida Office Bets on Nonprofit Finance Needs

Updated Category News Views 50

A Local Flag Planted After Years of Work Florida nonprofits do not need another consultant waving a glossy slide deck around; they need clean books, grant compliance, and somebody who can tell them where the cash is going before the lights start blinking red. That is the practical opening YPTC is chasing with a Jacksonville-based Florida office, its sixteenth office...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover the Luxury of the Mercedes-Benz EQS: Test Drive Today

Updated Category News Views 200

Experience the Mercedes-Benz EQS Test Drive at Arrowhead Drivers have a wonderful opportunity to immerse themselves in the world of electric luxury with the EQS at Mercedes-Benz of Arrowhead. This dealership is dedicated to providing an exceptional test drive experience, allowing potential buyers to see why this vehicle stands out in its class. With the surge in interest...

Continue Reading
Upcoming Financial Results and Conference Call for PROREIT

Updated Category News Views 103

Important Announcement from PROREIT PRO Real Estate Investment Trust, commonly known as PROREIT, is gearing up to share its financial performance for the 2024 fiscal year as well as the results for the fourth quarter. Scheduled for post-market release, this wave of data promises valuable insights for investors and stakeholders alike. The release will take place on an...

Continue Reading
Hearthside Food Solutions Seeks Bankruptcy Protection Amid Debt Issues

Updated Category News Views 293

Hearthside Food Solutions Files for Bankruptcy Hearthside Food Solutions has taken a significant step by filing for bankruptcy protection amidst deep financial strains. This decision comes as the company aims to reduce its staggering $1.9 billion debt and undertake a much-needed restructuring of its operations. The move follows troubling investigations into allegations of...

Continue Reading
New Affordable Housing Community Launched in San Antonio

Updated Category News Views 149

New Affordable Housing Community Opens in San Antonio The NRP Group, a leading developer known for its quality multifamily housing, has partnered with the City of San Antonio to celebrate the opening of a new affordable housing community called Los Arcos at Vida. This significant development, featuring 324 rental units, represents a crucial step forward in the ongoing...

Continue Reading
Insights on Dollar Tree's Stock Activity and Market Trends

Updated Category News Views 131

Understanding Dollar Tree's Investment Climate In the recent environment of stock trading, Dollar Tree (NASDAQ: DLTR) has caught the attention of many investors. A noticeable trend has emerged among deep-pocketed investors adopting a bearish stance towards the company. This change in sentiment is worth noting for those keeping tabs on the market. Market Activity Insights...

Continue Reading